Rapid Changes In Plaque Composition And Morphology After Intensive Lipid Lowering Therapy: Study With Serial Coronary Ct Angiography

Although intensive lipid lowering by statins can enhance plaque stability, few data exist regarding how early statins change plaque composition and morphology in clinical setting. Therefore, to examine early changes in plaque composition and morphology by intensive lipid lowering with statins, we evaluate coronary plaques from acute coronary syndrome (ACS) before and 3 weeks after lipid lowering by coronary CT angiography. We enrolled 110 patients with suspected ACS and underwent coronary CT. We defined plaque as unstable when CT number of plaque<50HU and remodeling index (lesion diameter/reference diameter) > 1.10. Rosuvastatin (5 mg/day) or atorvastatin (20 mg/day) were introduced to reduce low density lipoprotein cholesterol (LDL-C). Then, CT was again performed by the same condition 3 weeks after lipid lowering therapy. Total 10 patients (8 men, mean age 72.0 years), in whom informed consent regarding serial CT examination was obtained, were analyzed. Among them, 4 patients who denied to have intensive lipid lowering were served as controls. In remaining 6 patients, LDL-C reduced from 129.5 +/- 26.9 mg/dl to 68.5 +/- 11.1 mg/dl after statin treatment. Under these conditions, CT number of the targeted plaque significantly increased from 16.0 +/- 15.9 to 50.8 coproduct 35.0 HU (p<0.05) and remodeling index decreased from 1.22 +/- 0.11 to 1.11 +/- 0.06 (p<0.05), although these values substantially unchanged in controls. These results demonstrate that MDCT-determined plaque composition as well as volume could be changed within 3 weeks after intensive lipid lowering. This may explain acute effects of statins in treatment of acute coronary syndrome.